183 related articles for article (PubMed ID: 9255534)
1. Diagnosis and prevention of post-ERCP pancreatitis.
Tittobello A
Endoscopy; 1997 May; 29(4):285-7. PubMed ID: 9255534
[No Abstract] [Full Text] [Related]
2. The Prevention, recognition and treatment of post-ERCP pancreatitis.
Badalov N; Tenner S; Baillie J
JOP; 2009 Mar; 10(2):88-97. PubMed ID: 19287099
[No Abstract] [Full Text] [Related]
3. [Can post-ERCP acute pancreatitis be predicted and prevented?].
Hastier P
Gastroenterol Clin Biol; 2001 Jan; 25(1 Suppl):1S140-50. PubMed ID: 11223587
[No Abstract] [Full Text] [Related]
4. Incidence, risk factors, and prevention of post-ERCP pancreatitis.
Cooper ST; Slivka A
Gastroenterol Clin North Am; 2007 Jun; 36(2):259-76, vii-viii. PubMed ID: 17533078
[TBL] [Abstract][Full Text] [Related]
5. Simple measures to prevent post-ERCP pancreatitis?
Testoni PA
Gut; 2008 Sep; 57(9):1197-8. PubMed ID: 18719133
[No Abstract] [Full Text] [Related]
6. Preventing post-ERCP pancreatitis: where are we?
Testoni PA
JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.
Sherman S; Cheng CL; Costamagna G; Binmoeller KF; Puespoek A; Aithal GP; Kozarek RA; Chen YK; Van Steenbergen W; Tenner S; Freeman M; Monroe P; Geffner M; Deviere J;
Pancreas; 2009 Apr; 38(3):267-74. PubMed ID: 19214137
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin for post-ERCP pancreatitis prophylaxis: another attempt at the Holy Grail.
Wagh MS; Sherman S
Am J Gastroenterol; 2007 May; 102(5):984-6. PubMed ID: 17489783
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis.
Budzyńska A; Marek T; Nowak A; Kaczor R; Nowakowska-Dulawa E
Endoscopy; 2001 Sep; 33(9):766-72. PubMed ID: 11558030
[TBL] [Abstract][Full Text] [Related]
10. [Can post-ERCP acute pancreatitis be predicted and prevented?].
Heyries L
Gastroenterol Clin Biol; 2001 Jan; 25(1 Suppl):1S241-6. PubMed ID: 11223596
[No Abstract] [Full Text] [Related]
11. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
[TBL] [Abstract][Full Text] [Related]
12. Post-ERCP pancreatitis: new momentum.
Rabenstein T; Hahn EG
Endoscopy; 2002 Apr; 34(4):325-9. PubMed ID: 11932791
[No Abstract] [Full Text] [Related]
13. Post-ERCP pancreatitis and its prevention.
Frank CD; Adler DG
Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):680-8. PubMed ID: 17130878
[TBL] [Abstract][Full Text] [Related]
14. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
Poon RT; Fan ST
JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
[TBL] [Abstract][Full Text] [Related]
15. Use of corticosteriods in the prevention of post-ERCP pancreatitis: results of a controlled prospective study.
De Palma GD; Catanzano C
Am J Gastroenterol; 1999 Apr; 94(4):982-5. PubMed ID: 10201469
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systematic analysis of benefits and associated risks.
Andriulli A; Forlano R; Napolitano G; Conoscitore P; Caruso N; Pilotto A; Di Sebastiano PL; Leandro G
Digestion; 2007; 75(2-3):156-63. PubMed ID: 17684365
[TBL] [Abstract][Full Text] [Related]
17. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
Choi CW; Kang DH; Kim GH; Eum JS; Lee SM; Song GA; Kim DU; Kim ID; Cho M
Gastrointest Endosc; 2009 Apr; 69(4):e11-8. PubMed ID: 19327467
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy for the prevention of post-ERCP pancreatitis.
Foster E; Leung J
Am J Gastroenterol; 2007 Jan; 102(1):52-5. PubMed ID: 17266688
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.
Masci E; Mariani A; Curioni S; Testoni PA
Endoscopy; 2003 Oct; 35(10):830-4. PubMed ID: 14551860
[TBL] [Abstract][Full Text] [Related]
20. ERCP and biliary endoscopic sphincterotomy-induced pancreatitis.
Gottlieb K; Sherman S
Gastrointest Endosc Clin N Am; 1998 Jan; 8(1):87-114. PubMed ID: 9405753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
